420 related articles for article (PubMed ID: 28641308)
1. Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies.
Sharma R; Huang X; Brekken RA; Schroit AJ
Br J Cancer; 2017 Aug; 117(4):545-552. PubMed ID: 28641308
[TBL] [Abstract][Full Text] [Related]
2. Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study.
Lea J; Sharma R; Yang F; Zhu H; Ward ES; Schroit AJ
Oncotarget; 2017 Feb; 8(9):14395-14407. PubMed ID: 28122335
[TBL] [Abstract][Full Text] [Related]
3. Plasma exosome microRNAs are indicative of breast cancer.
Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
[TBL] [Abstract][Full Text] [Related]
4. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
[TBL] [Abstract][Full Text] [Related]
5. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches.
Zarovni N; Corrado A; Guazzi P; Zocco D; Lari E; Radano G; Muhhina J; Fondelli C; Gavrilova J; Chiesi A
Methods; 2015 Oct; 87():46-58. PubMed ID: 26044649
[TBL] [Abstract][Full Text] [Related]
6. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.
Madhavan B; Yue S; Galli U; Rana S; Gross W; Müller M; Giese NA; Kalthoff H; Becker T; Büchler MW; Zöller M
Int J Cancer; 2015 Jun; 136(11):2616-27. PubMed ID: 25388097
[TBL] [Abstract][Full Text] [Related]
7. Integrated Analysis of Exosomal Protein Biomarkers on Alternating Current Electrokinetic Chips Enables Rapid Detection of Pancreatic Cancer in Patient Blood.
Lewis JM; Vyas AD; Qiu Y; Messer KS; White R; Heller MJ
ACS Nano; 2018 Apr; 12(4):3311-3320. PubMed ID: 29570265
[TBL] [Abstract][Full Text] [Related]
8. Detection of exosomal biomarker by electric field-induced release and measurement (EFIRM).
Tu M; Wei F; Yang J; Wong D
J Vis Exp; 2015 Jan; (95):52439. PubMed ID: 25650727
[TBL] [Abstract][Full Text] [Related]
9. Molecular Detection and Analysis of Exosomes Using Surface-Enhanced Raman Scattering Gold Nanorods and a Miniaturized Device.
Kwizera EA; O'Connor R; Vinduska V; Williams M; Butch ER; Snyder SE; Chen X; Huang X
Theranostics; 2018; 8(10):2722-2738. PubMed ID: 29774071
[TBL] [Abstract][Full Text] [Related]
10. Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.
Wang M; Ji S; Shao G; Zhang J; Zhao K; Wang Z; Wu A
Clin Transl Oncol; 2018 Jul; 20(7):906-911. PubMed ID: 29143228
[TBL] [Abstract][Full Text] [Related]
11. Single-Exosome-Counting Immunoassays for Cancer Diagnostics.
Liu C; Xu X; Li B; Situ B; Pan W; Hu Y; An T; Yao S; Zheng L
Nano Lett; 2018 Jul; 18(7):4226-4232. PubMed ID: 29888919
[TBL] [Abstract][Full Text] [Related]
12. Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma.
López-Cobo S; Campos-Silva C; Moyano A; Oliveira-Rodríguez M; Paschen A; Yáñez-Mó M; Blanco-López MC; Valés-Gómez M
J Nanobiotechnology; 2018 May; 16(1):47. PubMed ID: 29720199
[TBL] [Abstract][Full Text] [Related]
13. Regulation of exosome release from mammary epithelial and breast cancer cells - a new regulatory pathway.
Riches A; Campbell E; Borger E; Powis S
Eur J Cancer; 2014 Mar; 50(5):1025-34. PubMed ID: 24462375
[TBL] [Abstract][Full Text] [Related]
14. Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis.
Zhang W; Ou X; Wu X
Int J Oncol; 2019 May; 54(5):1719-1733. PubMed ID: 30864689
[TBL] [Abstract][Full Text] [Related]
15. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.
Keller S; König AK; Marmé F; Runz S; Wolterink S; Koensgen D; Mustea A; Sehouli J; Altevogt P
Cancer Lett; 2009 Jun; 278(1):73-81. PubMed ID: 19188015
[TBL] [Abstract][Full Text] [Related]
16. Direct isolation and characterization of circulating exosomes from biological samples using magnetic nanowires.
Lim J; Choi M; Lee H; Kim YH; Han JY; Lee ES; Cho Y
J Nanobiotechnology; 2019 Jan; 17(1):1. PubMed ID: 30612562
[TBL] [Abstract][Full Text] [Related]
17. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer.
Joyce DP; Kerin MJ; Dwyer RM
Int J Cancer; 2016 Oct; 139(7):1443-8. PubMed ID: 27170104
[TBL] [Abstract][Full Text] [Related]
18. Role of exosomal proteins in cancer diagnosis.
Li W; Li C; Zhou T; Liu X; Liu X; Li X; Chen D
Mol Cancer; 2017 Aug; 16(1):145. PubMed ID: 28851367
[TBL] [Abstract][Full Text] [Related]
19. Detection of exosomal tyrosine receptor kinase B as a potential biomarker in ovarian cancer.
Li W; Lu Y; Yu X; Yong M; Ma D; Gao Q
J Cell Biochem; 2019 Apr; 120(4):6361-6369. PubMed ID: 30304550
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer.
Tao L; Zhou J; Yuan C; Zhang L; Li D; Si D; Xiu D; Zhong L
Metabolomics; 2019 May; 15(6):86. PubMed ID: 31147790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
